CryoMass Technologies Inc.
CryoMass Technologies Inc.
CryoMass Technologies Inc develops and licenses cutting-edge equipment and processes to refine harvested cannabis, hemp, and other premium crops.
The company’s patented technology harnesses liquid nitrogen to reduce biomass and then efficiently isolate, collect and preserve delicate resin glands (trichomes) containing prized compounds like cannabinoids and terpenes.
Our Company’s Technology
Building on this technology, CryoMass has engineered its premier Trichome Separation unit (CryoSift Separator™), optimized via patented cryogenic processes to rapidly capture intact, high-value cannabis and hemp trichomes (CryoSift™). Much like sugar and flour refinements, the resulting CryoSift™ concentrate is a superior product compared to unprocessed biomass.
For cultivators, reducing biomass into CryoSift™ slashes volume up to 80%, dramatically lowering storage, handling, and transportation costs. Properly stored, CryoSift™ prevents potency and terpene degradation, preserving value. For processors, the minimized input volume also enables considerable cost savings and logistics advantages. Extracting from CryoSift™ using solvents and manufacturing solventless products unlocks industrial scale yields unattainable otherwise.
CryoMass anticipates its efficiencies will catalyze industry-wide shifts in cannabis and hemp post-harvest methods. Additionally, the technology shows promise for diverse trichome-rich plants.
Our Leadership Team
CryoMass Technologies is led by an extremely experienced and talented group of individuals who offer perspectives based on their diverse backgrounds and skill sets. From our corporate officers to our board of directors, the company is well situated for future growth.
Christian Noël
Chief Executive Officer
Christian Noël is a trusted investor and business strategist, who has held senior positions in financial and investment organizations in Montreal, Canada, for the last 21 years.
Blair Mullin
Chief Financial Officer
(Philip) Blair Mullin is managing director of Somerset Associates LLC, a CFO, accounting, tax and financial consulting company, and serves on the board of CanaQuest Medical Corp.
Patricia Kovacevic
General Counsel & Head of External Affairs
An experienced legal and compliance department leader, Patricia I. Kovacevic’s career comprises leading senior legal and regulatory positions with FDA-regulated multinationals.
Board of Directors
Dr. Delon Human
Chairman of the Board
Dr. Delon Human, M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA is a recognized global health leader, published author, lecturer and healthcare consultant.
Mario Gobbo
Director
Mario Gobbo has 35 years of banking and corporate finance experience in healthcare and energy.
Mark Radke
Director
Mark Radke is a lawyer with a distinguished career in the area of financial services, specializing in federal securities regulation.
Simon Langelier
Director
Simon Langelier has extensive experience in the international tobacco industry and is currently a director of Imperial Brands PLC, after a 30-year career with Philip Morris International.
Christian Noël
CEO & Director
Christian Noël is a trusted investor and business strategist, who has held senior positions in financial and investment organizations in Montreal, Canada, for the last 21 years.
Investor Information
Regulatory Filings
Overview
CryoMass Technologies Inc (formerly Andina Gold, Redwood Green Corp.) regulatory filings are available at EDGAR, here – SEC CIK#0001533030 – and accessible by date via the categories below.
Company’s State location: CO | State of Inc.: NV | Fiscal Year End: 12/31
CryoMass Technologies Inc. changed its company name from Andina Gold Corp. in August 2021, prior to that, it changed its company name from Redwood Green Corp. in October 2019, previously First Colombia Development Corp.
Frequently Asked Questions
CryoMass Technologies’s principal address is 1001 Bannock Street, Denver, CO 80204 USA.
Yes. CryoMass Technologies trades on the U.S. OTCQB® under the ticker symbol “CRYM”. CryoMass Technologies common shares may be purchased through your online brokerage account or through your registered investment broker.
CryoMass Technologies’s regulatory filings can be viewed at the SEC’s EDGAR database by searching on the name CryoMass Technologies, Inc. or our SEC CIK number, 0001533030. Additionally, our filings are posted at CryoMass.com on the Investors page.
CryoMass Technologies’s transfer agent and registrar for the common shares is Transhare, Bayside Center 1, 17755 North US Highway 19 Suite 140, Clearwater, Fl 33764 USA. Contact Kim Whiteside at (303) 662-1112 or [email protected].
If you are a registered stockholder with questions about your holdings or you need to make changes to your account, please contact CryoMass Technologies’s transfer agent, Transhare. If you own shares through a brokerage account, please contact the broker responsible for your account.
Please contact CryoMass Technologies Inc.’s Investor Relations department: [email protected] or +1 303 222 8092.